NeoNavia® is a modern biopsy system with a patented pulse technology intended to be used for ultrasound-guided tissue sampling and consists of a base unit, a hand unit and three types of biopsy needles. The main advantage of the product is the ability to take several types of biopsy samples thanks to the three different probes.
Each type of needle is powered by the new pulse technology, which provides more controlled needle insertion and precise placement of the needle in the tumour, while enabling high quality tissue samples from both breast and lymph nodes.
The major challenge was to re-engineer the handheld drive unit from single-use to reusable, while making it compatible with three different needle variants with the goal of completely replacing all other ultrasound-guided breast biopsy instruments on the market.
Read more about NeoDynamics and NeoNavia®
Read more about Etteplan MedTech
NeoDynamics AB (publ) is a Swedish medical technology company working to improve the diagnosis and treatment of cancer. The company has an innovative biopsy system, NeoNavia®. The biopsy system is based on a patented pulse technology, based on research conducted at Karolinska Institutet in Sweden. NeoNavia® is being evaluated for breast cancer diagnosis at leading clinics in the UK, Germany and Sweden.